Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Other hematologic neoplasm 1CNS 1

Conditions

Spinal Cord Neoplasms 1Optic Nerve Glioma 1Medulloblastoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Radiotherapy 6Psychiatric Rehabilitation 6Filgrastim 6Methylprednisolone 5Melphalan 5Flow Cytometry 5Cyclophosphamide 5Therapeutics 4sargramostim 3Topotecan 3Thiotepa 3Polymerase Chain Reaction 3Early Intervention, Educational 3Dexamethasone 3Caspofungin 3Carboplatin 3Calcium Dobesilate 3Busulfan 3Antilymphocyte Serum 3liposomal amphotericin B 2Vorinostat 2Voriconazole 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Fentanyl 2Carmustine 2Aprepitant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × CK0238273 × CNS × Clear all
NCT00363272 2013-01-16

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡